Celadon Pharmaceuticals plc (CEL) ORD GBP0.01
1.25p
(9.09%)
- Add to watchlist
- Create an alert
- This stock can be held in a
1.25p
(9.09%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
1.25p
(9.09%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
12.50p
13.25p
130.00p
£9.12 million
13.75p
12.00p
12.50p
n/a
1.75p (11.29%) Previous:
1.75p
35,906
n/a
1,500
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/12/2023 | 31/12/2022 |
|---|---|---|
| Revenue (£m) | 0.07 | 0.02 |
| Profit before tax (£m) | (7.52) | (18.12) |
| Adjusted EPS (p): | (11.50) | (29.70) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Celadon Pharmaceuticals finance chief to step down
30 September 2024 11:08
-
Celadon inks partnership with Denmark's Valeos
11 September 2024 15:52
-
Celadon confident in seeing through funding challenges
23 August 2024 11:58
-
Update on Financial Position
18 November 2024 07:00
-
New Sales Contract with a Healthcare Company
2 October 2024 07:00
-
Departure of Chief Financial Officer
30 September 2024 07:05
Annual & interim reports
Annual & interim reports are not available for this stock.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.